Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

CorMedix (CRMD) Return on Capital Employed: 2012-2025

Historic Return on Capital Employed for CorMedix (CRMD) over the last 9 years, with Sep 2025 value amounting to 0.28%.

  • CorMedix's Return on Capital Employed rose 121.00% to 0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28%, marking a year-over-year increase of 121.00%. This contributed to the annual value of -0.52% for FY2022, which is 3.00% up from last year.
  • CorMedix's Return on Capital Employed amounted to 0.28% in Q3 2025, which was down 3.01% from 0.29% recorded in Q2 2025.
  • CorMedix's Return on Capital Employed's 5-year high stood at 0.29% during Q2 2025, with a 5-year trough of -1.05% in Q2 2024.
  • Moreover, its 3-year median value for Return on Capital Employed was -0.62% (2023), whereas its average is -0.43%.
  • As far as peak fluctuations go, CorMedix's Return on Capital Employed dropped by 30bps in 2024, and later soared by 134bps in 2025.
  • CorMedix's Return on Capital Employed (Quarterly) stood at -0.44% in 2021, then decreased by 11bps to -0.55% in 2022, then declined by 12bps to -0.63% in 2023, then decreased by 30bps to -0.35% in 2024, then spiked by 121bps to 0.28% in 2025.
  • Its Return on Capital Employed stands at 0.28% for Q3 2025, versus 0.29% for Q2 2025 and 0.14% for Q1 2025.